The prevalence of Lewy body pathology across nine international community-based cohorts
Brain · 04.11.2026 · 149 (11) · 3923-3938
DOI: 10.1093/brain/awag112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 26.03.2026. Verfasst von Lucy L Gibson und 22 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Healthy Brain Ageing, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London SE5 9RS, UK. Hauptthemen laut MEDLINE: Lewy Body Disease, Lewy Bodies, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, Seattle Alzheimer's Disease Brain Cell Atlas, Alzheimer's Association.
Abstract (Originalsprache)
Reported prevalence estimates of Lewy body pathology (LBP) vary widely, often without considering brain regional distributions or demographic influences. Large, population-representative autopsy cohorts are needed to provide estimates and clarify the distribution and clinical implications of LBP. Neuropathological, genetic and clinical data were pooled from nine community- or population-based brain autopsy cohorts in the USA (n = 6), Brazil, Austria and Finland (n = 7309 total; 59% women; mean age of death 84.2 years). Cognitive status was available for 6166 participants: dementia (38.5%), mild cognitive impairment (14.8%) and cognitively unimpaired (47.0%). Frequency of LBP was examined by anatomical distribution (neocortical, limbic, brainstem, amygdala, olfactory) and stratified by covariates. Prevalence was calculated in meta-analysis, and mixed-effect logistic regression examined associations with sex, cognitive status, Alzheimer’s disease neuropathological change (ADNC) and limbic-predominant age-related transactive response DNA-binding protein (TDP)-43 encephalopathy neuropathologic change (LATE-NC) co-pathology. Overall, 27.3% of participants had LBP: neocortical 8.4%, limbic 6.8%, brainstem 4.8%, amygdala 3.7% and olfactory 3.6%. Neocortical LBP was associated with dementia [present in 15%; odds ratio (OR) = 4.06 (95% confidience interval (CI) 3.24–5.10)] and with increased odds of ADNC [OR = 2.30 (95% CI 1.88–2.81)] and LATE-NC [OR = 2.03 (95% CI 1.69–2.44)]. Sex differences were not observed in the frequencies of neocortical or limbic LBP. However, amygdala-predominant LBP was more frequent in women [OR = 1.53 (95% CI 1.06–2.21)] whereas brainstem-predominant LBP was more common in men [OR = 0.64 (95% CI 0.49–0.84)]. Additionally, amygdala-predominant LBP was associated with increased odds of comorbid ADNC [OR = 12.7 (95% CI 5.30–30.6)] while brainstem-predominant LBP was not associated with greater odds of ADNC co-pathology [OR = 0.88 (95% CI 0.67–1.16)]. Pooling data from large, international community-based autopsy cohorts allows for more robust estimates of region-specific LBP prevalence and their associations with cognitive status. The observed sex- and co-pathology-specific differences in brainstem and amygdala-predominant LBP highlight potential biological heterogeneity and suggest that distinct disease pathways may underlie these patterns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Healthy Brain Ageing, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London SE5 9RS, UK.
- South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK.
- Division of Geriatrics, University of Sao Paulo Medical School, Sao Paulo 05508-220, Brazil.
- Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
- Department of Epidemiology, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA.
- Department of Neurology and Epidemiology, Irvine School of Medicine, University of California, Irvine, CA 92617, USA.
ORCID-Profile: Lucy L Gibson, Claudia K Suemoto, Alifiya Kapasi, Gabor G Kovacs, Liisa Myllykangas, Rod Walker
Förderung
- NIMH NIH HHS
- Seattle Alzheimer's Disease Brain Cell Atlas
- Alzheimer's Association
- US Department of Defense
- NINDS NIH HHS
- Newcastle University
- NIA NIH HHS
- Alzheimer's Society and Alzheimer's Research UK
Zitieren
APA
Gibson, L. L., Suemoto, C. K., Attems, J., Abner, E. L., Corrada, M. M., Gomez-Isaza, L., Grinberg, L. T., Kapasi, A., Jicha, G. A., Kawas, C., Keene, C. D., Kovacs, G. G., Latimer, C. S., Leite, R. E. P., Montine, T., Myllykangas, L., Neltner, A. M., Troncoso, J., Walker, K. A., …, & Nelson, P. T. (2026). The prevalence of Lewy body pathology across nine international community-based cohorts. Brain, 149(11), 3923-3938. https://doi.org/10.1093/brain/awag112
Vancouver
Gibson LL, Suemoto CK, Attems J, Abner EL, Corrada MM, Gomez-Isaza L, et al. The prevalence of Lewy body pathology across nine international community-based cohorts. Brain. 2026;149(11):3923-3938. doi:10.1093/brain/awag112
BibTeX
@article{Gibson2026,
author = {Gibson, Lucy L and Suemoto, Claudia K and Attems, Johannes and Abner, Erin L and Corrada, Maria M and Gomez-Isaza, Laura and Grinberg, Lea T and Kapasi, Alifiya and Jicha, Gregory A and Kawas, Claudia and Keene, C Dirk and Kovacs, Gabor G and Latimer, Caitlin S and Leite, Renata E P and Montine, Thomas and Myllykangas, Liisa and Neltner, Allison M and Troncoso, Juan and Walker, Keenan A and Walker, Rod and Wang, Shih-Hsiu J and Aarsland, Dag and Nelson, Peter T},
title = {The prevalence of Lewy body pathology across nine international community-based cohorts},
journal = {Brain},
year = {2026},
volume = {149},
number = {11},
pages = {3923--3938},
doi = {10.1093/brain/awag112}
}
EUVIMED